|
Albo, D; Rothman, V L; Roberts, D D et al. (2000) Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor. Br J Cancer 83:298-306
|
|
Albo, D; Berger, D H; Vogel, J et al. (1999) Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer. J Gastrointest Surg 3:411-7
|
|
Albo, D; Berger, D H; Rothman, V L et al. (1999) Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion. J Surg Res 82:331-8
|
|
Roth, J J; Sung, J J; Granick, M S et al. (1999) Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-clycine receptor in fetal wounds. Ann Plast Surg 42:553-63
|
|
Roth, J J; Albo, D; Rothman, V L et al. (1998) Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancer. Ann Plast Surg 40:494-501
|
|
Albo, D; Berger, D H; Tuszynski, G P (1998) The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion. J Surg Res 76:86-90
|
|
Qian, X; Wang, T N; Rothman, V L et al. (1997) Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 235:403-12
|
|
Albo, D; Berger, D H; Wang, T N et al. (1997) Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Surgery 122:493-9; discussion 499-500
|
|
Tuszynski, G P; Wang, T N; Berger, D (1997) Adhesive proteins and the hematogenous spread of cancer. Acta Haematol 97:29-39
|
|
Roth, J J; Reiver, D M; Granick, M S et al. (1997) Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors. Histol Histopathol 12:1013-8
|
Showing the most recent 10 out of 13 publications
